Literature DB >> 1393577

Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice.

T P Semenova1, M K Ticku.   

Abstract

The effect of antagonists of serotonin (5-HT) receptor subtypes and alpha 2-adrenoceptors was investigated on audiogenic seizures and locomotor activity in DBA/2 mice. 5HT1c receptor antagonists (mianserin and cyproheptadine), 5-HT3 receptor antagonist (zacopride) and 5-HT4 receptor antagonist (ICS 205-930) increased the latency of audiogenic seizures and decreased the severity of convulsions in young (20-27 days old) DBA/2 mice. However, the effect of these antagonists varied in older (30-37 days old) mice. Ketanserin, 5-HT2 receptor antagonist, was devoid of any activity on audiogenic seizures. Yohimbine (0.5 mg/kg, i.p.), an alpha 2-adrenoceptor antagonist, increased the severity of audiogenic seizures, and the anti-convulsant effect of 5-HT receptor subtypes antagonists became more pronounced in the presence of yohimbine. 5-HT3 and 5-HT4 receptor antagonists produced hypolocomotor activity in young mice whereas 5-HT1c and 5-HT2 receptor antagonists were devoid of any effect on locomotor activity. Yohimbine did not induce any effect on locomotor activity but the mice exhibited more pronounced hypolocomotor activity following the administration of 5-HT3, 5-HT4 and 5HT1c receptor antagonists in the presence of yohimbine. However, the results varied with these agents in the older mice. These observations implicate a role of 5-HT1c, 5-HT3, 5-HT4 and alpha 2-adrenoceptors in audiogenic seizures in young DBA/2 mice, and 5-HT3 and 5-HT4 receptors in locomotor activity in these mice. Furthermore, these results also suggest an interaction between 5-HT receptors and alpha 2-adrenoceptors, and differential development patterns of various 5-HT receptor subtypes in the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393577     DOI: 10.1016/0006-8993(92)91580-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Transient paroxysmal dystonia in an infant possibly induced by cisapride.

Authors:  L Angelini; G Zorzi; V Rumi; N Nardocci; T Mennini
Journal:  Ital J Neurol Sci       Date:  1996-04

2.  Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene.

Authors:  Christoph Fehr; Renee L Shirley; John K Belknap; John C Crabbe; Kari J Buck
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

3.  Effect of ramosetron, a 5-HT3 receptor antagonist on the severity of seizures and memory impairment in electrical amygdala kindled rats.

Authors:  Zeynab Sayahi; Alireza Komaki; Masoud Saidi Jam; Seyed Asaad Karimi; Safoura Raoufi; Parastoo Mardani; Marzieh Naderishahab; Abdolrahman Sarihi; Javad Mirnajafi-Zadeh
Journal:  J Physiol Sci       Date:  2022-01-16       Impact factor: 2.781

Review 4.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

5.  Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.

Authors:  Kinga K Borowicz; Monika Banach; Radosław Zarczuk; Dariusz Lukasik; Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

6.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

7.  5-HT2C and GABAB receptors influence handling-induced convulsion severity in chromosome 4 congenic and DBA/2J background strain mice.

Authors:  Matthew T Reilly; Lauren C Milner; Renee L Shirley; John C Crabbe; Kari J Buck
Journal:  Brain Res       Date:  2008-01-18       Impact factor: 3.252

Review 8.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

9.  Seizure developed after palonosetron intravenous injection during recovery from general anesthesia -A case report-.

Authors:  Pyung-Gul Park; Hwa-Yong Shin; Hyun Kang; Yong Hun Jung; Young-Cheol Woo; Jin-Yun Kim; Gill Hoi Koo; Sun Gyoo Park; Chong Wha Baek
Journal:  Korean J Anesthesiol       Date:  2012-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.